PU02.01 Subtle variations in HIV-1 subtype C env sequence features obtained from a slow progressing Indian donor and their association with sensitivity to neutralizing antibodies with distinct epitope specificitiesPublication OnlyBroadly neutralizing antibodies
PU01.09 Supporting adolescent girls and young women to adhere to oral PrEP; experiences of counsellors at the Kampala sitePublication OnlyBehavioural and social science research
PE26.01 Surge strategies improve HIV testing efficiency and linkage to treatment among female sex workers in Nairobi, KenyaE-posterTherapeutic vaccines, viral reservoirs and eradication/remission
OA11.03 Surveillance data from public and private primary care facilities uncover implementation successes and gaps during pre-exposure prophylaxis (PrEP) scale-up: results from the Jilinde project in KenyaOral Abstract SessionImplementation science, including structural interventions, PrEP & VMMC
PE11.02 Switching from F/TDF to F/TAF for HIV Pre-exposure Prophylaxis: An Analysis of the Real-World DataE-posterDiscovery and evaluation of biomedical agents
PE01.08 Syndemic conditions and PrEP use are independently associated with rectal inflammation in sexual minority menE-posterBehavioural and social science research
PE16.14 Targeted index partner HIV self-testing results in high positivity yield and reach for exposed HIV-uninfected contacts at elevated ongoing risk of HIV acquisition in KenyaE-posterImplementation science, including structural interventions, PrEP & VMMC
OA14.04 Targeting Sphingosine-1-phosphate signaling prevents cell-to-cell transmission of HIV-1Oral Abstract SessionTherapeutic vaccines, viral reservoirs and eradication/remission
OA22.03 Temporal and spatial characterization of SIV infection dynamics in rhesus macaque mucosal tissuesOral Abstract SessionMucosal immunity
PE23.03 Ten years of the AVAC Advocacy Fellows Program: An evaluationE-posterPolicy and advocacy
seek-warrow-warrow-eseek-e371 - 380 of 444 items